NCT02774590View on ClinicalTrials.gov

Timolol for the Treatment of Acne and Rosacea

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Acne VulgarisRosacea
Interventions
DRUG

Timolol

Apply timolol on half of the participant's face for 8 weeks. Then treat both sides of face for 8 weeks.

Trial Locations (1)

21209

Johns Hopkins Dermatology Department, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT02774590 - Timolol for the Treatment of Acne and Rosacea | Biotech Hunter | Biotech Hunter